NEUROMUSCULAR PREDICTORS OF VERTICAL JUMP PERFORMANCE IN NATIONAL-TEAM WRESTLERS: A CROSS-SECTIONAL STUDY

August 3, 2026 updated by: Esra BAYRAMOĞLU DEMİRDÖĞEN, Ahi Evran University Education and Research Hospital
The study will include national wrestlers studying at Kırşehir Ahi Evran University School of Physical Education and Sports who meet the inclusion criteria and agree to participate. Individuals who agree to participate will be evaluated on their grip strength, hand reaction times, balance, core muscle endurance, vertical jumps, dynamic (Y-balance test), and static balance.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The study will include national wrestlers studying at Kırşehir Ahi Evran University School of Physical Education and Sports who meet the inclusion criteria and agree to participate. Individuals who agree to participate will be evaluated on their grip strength, hand reaction times, balance, core muscle endurance, vertical jumps, dynamic (Y-balance test), and static balance.

Study Type

Observational

Enrollment (Estimated)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of active male national-team wrestlers enrolled at the Faculty of Sport Sciences, Kırşehir Ahi Evran University. Participants are currently engaged in regular wrestling training and national-team competition. Eligible wrestlers are selected from this defined population according to the prespecified inclusion and exclusion criteria.

Description

Inclusion Criteria:

  1. Being between 18-25 years old
  2. Being a national wrestler
  3. Not having experienced back pain, lower back pain, or lower extremity pain in the last 6 months
  4. Volunteering to participate in the study

Exclusion Criteria:

  1. Not being a national wrestler
  2. Failure to complete the tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
male national-team wrestlers
Other: Neuromuscular performance assessment protocol
Participants underwent a standardized, one-time neuromuscular performance assessment including handgrip strength, upper-extremity reaction time, vertical jump height, core muscle endurance, single-leg static balance, and Y-Balance Test performance. No therapeutic, exercise-training, or other researcher-assigned intervention was administered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean vertical jump height
Time Frame: During the single assessment session
Vertical jump performance will be assessed under standardized testing conditions. Each participant will perform three maximal vertical jump trials. Jump height will be recorded in centimeters, and the mean of the three trials will be used as the primary outcome measure. Higher values indicate better vertical jump performance.
During the single assessment session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ahi Evran University Education and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 4, 2026

Primary Completion (Estimated)

August 6, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

August 3, 2026

First Submitted That Met QC Criteria

August 3, 2026

First Posted (Actual)

August 6, 2026

Study Record Updates

Last Update Posted (Actual)

August 6, 2026

Last Update Submitted That Met QC Criteria

August 3, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • KAEU-EBAYRAMOGLUD-008

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

privacy of personal information

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe